Clinical inquiries: Do glucosamine and chondroitin worsen blood sugar control in diabetes?

Despite theoretical risks based on animal models given high intravenous doses, glucosamine/chondroitin (1500 mg/1200 mg daily) does not adversely affect short-term glycemic control for patients whose diabetes is well-controlled, or for those without diabetes or glucose intolerance (SOR: A, consisten...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of family practice 2006-12, Vol.55 (12), p.1091-1093
Hauptverfasser:	Marshall, Peter D, Poddar, Sourav, Tweed, Elizabeth M, Brandes, Lisa
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood Glucose - metabolism Chondroitin - administration & dosage Chondroitin - adverse effects Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - metabolism Drug Therapy, Combination Evidence-Based Medicine Glucosamine - administration & dosage Glucosamine - adverse effects Glycated Hemoglobin A - metabolism Humans Nonprescription Drugs - administration & dosage Nonprescription Drugs - adverse effects Osteoarthritis - complications Osteoarthritis - prevention & control Randomized Controlled Trials as Topic Reference Values
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!